CD Skripsi
Pola Sensitivitas Isolat Klinis Bakteri Gram Negatif Multiresisten Obat Terhadap Fosfomisin Dari Beberapa Rumah Sakit Kota Pekanbaru
Over the last few years, there has been a degradation in amount of effective antibiotics, coincide with the lack of new antibiotics relevant for the treatment of Gram negative multi-drug resistant organisms infections. This problem can be overcome by the assessment and re-introduction of old antibiotics such as fosfomycin. Fosfomycin is a bactericidal antibiotics that has a board spectrum. Some studies have found that 90% of the isolates of multi-drug resistant organisms are sensitive to fosfomycin. This study aimed to find out the sensitivity pattern of clinical isolate multi-drug resistant Gram negative bacteria to fosfomycin with descriptive cross sectional method. The sample used in this study is clinical isolates collection of Microbiology Laboratory Faculty of Medicine, University of Riau from Hospitals in Pekanbaru. The result of this study showed sensitivity of E.coli producing ESBL, K.pneumoniae producing ESBL, A.baumanii resistant meropenem, P.aeruginosa resistant meropenem and K.pneumoniae resistant meropenem to fosfomycin are 88%, 95%, 27%, 36% and 70%. Clinical isolates that have the highest sensitivity to fosfomycin is K.pneumoniae producing ESBL and the lowest sensitivity is A. baumanii resistant meropenem. Fosfomycin can be used as alternative therapy for infections caused by Gram-negative Multi-drug resistant organisms.
Keyword : Fosfomycin, Gram-negative, multi-drug resistant organisms
Tidak tersedia versi lain